Sarcoma
(Jan 2000)
Confirmed Angiosarcoma: Prognostic Factors and Outcome in 50
Prospectively Followed Patients
N. J. Espat,
J. J. Lewis,
J. M. Woodruff,
C. Antonescu,
J. Xia,
D. Leung,
M. F. Brennan
Affiliations
N. J. Espat
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
J. J. Lewis
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
J. M. Woodruff
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
C. Antonescu
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
J. Xia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
D. Leung
Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
M. F. Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
DOI
https://doi.org/10.1155/2000/575781
Journal volume & issue
Vol. 4,
no. 4
Abstract
Read online
Purpose. Angiosarcoma is a rare tumor with endothelial cell differentiation that may arise in any anatomic location.The purpose of this report was to identify prognostic factors on outcome in a group of prospectively followed patients with confirmed angiosarcoma.
WeChat QR code
Close
